TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ

Zhang,Xiaobo; Shi,Gang; Gao,Feng; Liu,Peng; Wang,Huaitao; Tan,Xiaodong

doi:10.3892/or.2019.6989

TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ

Authors:
- Xiaobo Zhang
- Gang Shi
- Feng Gao
- Peng Liu
- Huaitao Wang
- Xiaodong Tan
View Affiliations

Affiliations: Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110042, P.R. China, Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning 110042, P.R. China
Published online on: January 30, 2019 https://doi.org/10.3892/or.2019.6989
Pages: 2117-2125
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pancreatic cancer (PC), a malignancy of the digestive system, has one of the highest rates of metastasis and mortality. It is characterized by the detachment, migration, implantation and infiltration of tumor cells to form metastases or recurrent foci. Tetraspanin 1 (TSPAN1), a novel member of the TSPAN superfamily, is highly expressed in many types of cancer, including gastric, colon, liver and esophageal cancer. It has also been associated with lymph node metastasis, tumor recurrence and metastasis. However, the role of TSPAN1 in PC has not been fully elucidated. The aim of the present study was to determine the expression of TSPAN1 in human PC tissue samples and cell lines. Additionally, the functions of TSPAN1 in PC cell migration and invasion were assessed. The protein and gene expression of TSPAN1 was analyzed in clinical PC tissue samples and human PC cell lines (SW1990, BxPC3, Capan1 and PANC‑1) via immunohistochemistry, reverse transcription‑quantitative polymerase chain reaction and western blotting. The effect of TSPAN1 downregulation and overexpression in PC cells, via transfection with siRNA and pLNCX‑TSPAN1‑cDNA recombinant plasmid, respectively, on cell invasion and migration were assessed. Additionally, the mRNA expression of matrix metalloproteinase (MMP2) and MMP9 were determined. In clinical PC tissue samples, the expression of TSPAN1 was markedly increased when compared with normal pancreatic tissue samples. TSPAN1 was also highly expressed in PC cell lines compared with HPDE, a normal pancreatic cell line. Transfection with siRNA targeting TSPAN1 in PC cell lines significantly suppressed PC cell migration and invasion, and downregulated the expression of MMP2. However, there was no effect on MMP9. Consistently, PC cell migration and invasion together with MMP2 mRNA expression were markedly increased following TSPAN1 ectopic overexpression. The present study utilized small interfering RNAs (siRNA) targeted to phospholipase Cγ (PLCγ) to demonstrate that TSPAN1 siRNA suppressed PC cell migration and invasion, and MMP2 mRNA expression by blocking the translocation and phosphorylation of PLCγ. The results of the present study revealed that TSPAN1 has an important function in human PC cell migration and invasion by modulating MMP2 expression via PLCγ. Thus, the results indicate that the silencing of TSPAN1 may be a potential therapeutic target for the treatment of PC.

View Figures

View References

1	Vincent A, Herman J, Schuick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
3	Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP and Boffetta P: Pancreatic cancer: Overview of descriptive epidemiology. Mol Carcinog. 51:3–13. 2012. View Article : Google Scholar : PubMed/NCBI
4	Loos M, Kleeff J, Friess H and Büchler MW: Surgical treatment of pancreatic cancer. Ann N Y Acad Sci. 1138:169–180. 2008. View Article : Google Scholar : PubMed/NCBI
5	Mitchem JB, Hamilton N, Gao F, Hawkins WG, Linehan DC and Strasberg SM: Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. J Am Coll Surg. 214:46–52. 2012. View Article : Google Scholar : PubMed/NCBI
6	Nakai Y, Isayama H, Sasaki T, Sasahira N, Tsujino T, Toda N, Kogure H, Matsubara S, Ito Y, Togawa O, et al: A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study. Br J Cancer. 106:1934–1939. 2012. View Article : Google Scholar : PubMed/NCBI
7	Long Y, Sun Q, Wu J, Wang Y and Jiao S: Allogeneic cell-based immunotherapy combined with chemotherapy and targeted therapy in advanced pancreatic cancer with metastases: A case report. Oncol Lett. 7:1594–1598. 2014. View Article : Google Scholar : PubMed/NCBI
8	Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, et al: The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. J Gastrointest Oncol. 5:77–85. 2014.PubMed/NCBI
9	Hemler ME: Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 6:801–811. 2005. View Article : Google Scholar : PubMed/NCBI
10	Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M and Sánchez-Madrid F: Tetraspanin-enriched microdomains: A functional unit in cell plasma membranes. Trends Cell Biol. 19:434–446. 2009. View Article : Google Scholar : PubMed/NCBI
11	Stipp CS, Kolesnikova TV and Hemler ME: Functional domains in tetraspanins proteins. Trends Biochem Sci. 28:106–122. 2003. View Article : Google Scholar : PubMed/NCBI
12	Liu L, He B, Liu WM, Zhou D, Cox JV and Zhang XA: Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J Biol Chem. 282:31631–31642. 2007. View Article : Google Scholar : PubMed/NCBI
13	Richardson MM, Jennings LK and Zhang XA: Tetraspanins and tumor progression. Clin Exp Metastasis. 28:261–270. 2011. View Article : Google Scholar : PubMed/NCBI
14	Pedro AL: Functional implications of tetraspanin proteins in cancer biology. Cancer Science. 98:1666–1677. 2007. View Article : Google Scholar : PubMed/NCBI
15	Garcia-España A, Chung PJ, Sarkar IN, Stiner E, Sun TT and Desalle R: Appearance of new tetraspanin genes during vertebrate evolution. Genomics. 91:326–334. 2008. View Article : Google Scholar : PubMed/NCBI
16	Guo Q, Xia B, Zhang F, Richardson MM, Li M, Zhang JS, Chen F and Zhang XA: Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cell-cell adhesions. PLoS One. 7:e384642012. View Article : Google Scholar : PubMed/NCBI
17	Ke AW, Shi GM, Zhou J, Wu FZ, Ding ZB, Hu MY, Xu Y, Song ZJ, Wang ZJ, Wu JC, et al: Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology. 49:491–503. 2009. View Article : Google Scholar : PubMed/NCBI
18	Duan H, Qu L and Shou C: Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration. Cancer Cell Int. 14:1352014. View Article : Google Scholar : PubMed/NCBI
19	Chen L, Yuan D, Zhao R, Li H and Zhu J: Suppression of TSPAN1 by RNA interference inhibits proliferation and invasion of colon cancer cells in vitro. Tumori. 96:744–750. 2010. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Albrethsen J, Bøgebo R, Gammeltoft S, Olsen J, Winther B and Raskov H: Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1–3) in colon cancer serum and tumours: A biomarker study. BMC Cancer. 5:82005. View Article : Google Scholar : PubMed/NCBI
22	Cordeiro C and Freire AP: Digitonin permeabilization of Saccharomyces cerevisiae cells for in situ enzyme assay. Anal Biochem. 229:145–148. 1995. View Article : Google Scholar : PubMed/NCBI
23	Chen CA and Okayama H: Calcium phosphate-mediated gene transfer: A highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques. 6:632–638. 1988.PubMed/NCBI
24	Takahashi M, Sugiura T, Abe M, Ishii K and Shirasuna K: Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration. Int J Cancer. 121:1919–1929. 2007. View Article : Google Scholar : PubMed/NCBI
25	Fei Y, Wang J, Liu W, Zuo H, Qin J, Wang D, Zeng H and Liu Z: CD151 promotes cancer cell metastasis via integrins α3β1 and α6β1 in vitro. Mol Med Rep. 6:1226–1230. 2012. View Article : Google Scholar : PubMed/NCBI
26	Haeuw JF, Goetsch L, Bailly C and Corvaia N: Tetraspanin CD151 as a target for antibody-based cancer immunotherapy. Biochem Soc Trans. 39:553–558. 2011. View Article : Google Scholar : PubMed/NCBI
27	Chen L, Zhu Y, Li H, Wang GL, Wu YY, Lu YX, Qin J, Tuo J, Wang JL and Zhu J: Knockdown of TSPAN1 by RNA silencing and antisense technique inhibits proliferation and infiltration of human skin squamous carcinoma cells. Tumori. 96:289–295. 2010. View Article : Google Scholar : PubMed/NCBI
28	Hölters S, Anacker J, Jansen L, Beer-Grondke K, Dürst M and Rubio I: Tetraspanin 1 promotes invasiveness of cervical cancer cells. Int J Oncol. 43:503–512. 2013. View Article : Google Scholar : PubMed/NCBI
29	Lu Z, Luo T, Nie M, Pang T, Zhang X, Shen X, Ma L, Bi J, Wei G, Fang G and Xue X: TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573. FEBS Lett. 589:1988–1994. 2015. View Article : Google Scholar : PubMed/NCBI
30	Ellenrieder V, Adler G and Gress TM: Invasion and metastasis in pancreatic cancer. Ann Oncol. 10 (Suppl 4):S46–S50. 1999. View Article : Google Scholar
31	Nagase H and Woessner JF Jr: Matrix metalloproteinases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar : PubMed/NCBI
32	Curran S and Murray GI: Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 189:300–308. 1999. View Article : Google Scholar : PubMed/NCBI
33	Bramhall SR, Neoptolemos JP, Stamp GW and Lemoine NR: Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol. 182:347–355. 1997. View Article : Google Scholar : PubMed/NCBI
34	Khokha R and Denhardt DT: Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigenesis and tissue invasion. Invasion Metastasis. 9:391–405. 1989.PubMed/NCBI
35	Koshiba T, Hosotani R, Wada M, Fujimoto K, Lee JU, Doi R, Arii S and Imamura M: Detection of matrix metalloproteinase activity in human pancreatic cancer. Surg Today. 27:302–304. 1997. View Article : Google Scholar : PubMed/NCBI
36	Nagakawa Y, Aoki T, Kasuya K, Tsuchida A and Koyanagi Y: Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer. Pancreas. 24:169–178. 2002. View Article : Google Scholar : PubMed/NCBI